Regulation And Legal
Emcure Receives ₹577 Crore Income Tax Penalty
Emcure Pharmaceuticals discloses regulatory orders from the Income-tax Department imposing an aggregate penalty of ₹57.74 crore.
The penalty covers financial years 2014-15 to 2020-21 (assessment years
